TrialJAMA neurology2025

Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial.

Richard B Lipton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.